ActiMaris AG is pleased to participate with an active contribution at the Wound Congress EWMA 2023 in Milan, Italy. We are happy to share our latest research results with interested professionals who are looking for new therapeutic options. Our company aims to find new ways to improve the treatment of chronic wounds. We believe that this congress is a valuable opportunity to share our ideas and findings with the professional community. You are welcome to visit us at the congress at our booth. We look forward to seeing you.
At booth: 84b (Almeros / ActiMaris) you will find interesting and useful scientific and clinical information about the clinical use of ActiMaris products.
ActiMaris team leverages EWMA congress for strategic advancement and improved patient care
.
During the three-day EWMA Congress in Milan, the ActiMaris team was extremely engaged. We made numerous contacts and had intensive discussions with other companies. In addition, the congress provided an excellent opportunity to meet our leading distribution partners and discuss how to expand our collaboration, always with the goal of improving patient care.
The congress turned out to be extraordinarily successful for us. It allowed us to gain deep insights into the current wound market realities and revealed to us the preferred therapeutic approaches as well as innovations in technology. These insights will enable us to better target our products as a component of a combined therapy in the treatment of chronic wounds.
ActiMaris® – our contribution
OXYGEN-ROS-REDOX COMPLEX NEW PERSPECTIVE ON AN OLD CONCEPT OF NATURE
Damir Marincic, MD
Quorum Medis Center, (St.Gallen, SWITZERLAND)
Background and Aims
Medical science is accelerating and keeps advancing, but we are stagnating and stubbornly refuse to apply new knowledge to our therapy concepts. Already 10 years ago, 2013 EWMA wrote in a wound document: New treatment paradigms are needed to address the burgeoning problem of non-healing wounds, because the current standard of care has proven marginally effective. We must analyze and solve the problem of treatment strategy, because with a present strategy we have a case of tail wagging the dog.
Method
We conducted literature research of the last 12 years, analyzed our experimental work and clinical results on more then 30’000 patients with more than a million applications.
Results
Our research results speak for a need of paradigm shift based on the Redox code as a part of complementary codes. Redox code constitutes a complex network with 4 basic principles and physical-chemical parameters, such as: pH, Redox potential, electric conductivity, hyperosmolarity, physical dissolved oxygen / pO2. They build a nexus of molecular dynamics, biological kinetics, biological cybernetics with pH modulation during healing processes, that we must consider in our therapy concepts.
Conclusion
Based on our research outcomes the local therapy concept is quite simple and can be summarized within the framework of slogans:
- SUPPLY the tissue with oxygen, ROS (reactive oxygen species), energy and neutral-basic pH
- ENSURE a healthy environment for the wound
- REDUCE the microbial and tissue burden, as well as the therapeutic overload
- SPEAK the language of cells and SUPPORT their signaling and repair pathways
ActiMars Complex
Dr. Davide Bottini et al. is participating in EMWA 2023 with a poster (EP538).
- USO DELL’OSSIGENO SINGOLETTO,L ACIDO IPOCLOROSO E NITRITO DI SODIO NELLA GESTIONE DELL’INFEZIONE POST CHIRURGICA IN UN CASO DI CHIRURGIA DELL’ORECCHIO ETERNO (ACTIMARIS)
Prof. Dr. Barbara De Angelis will participate in EMWA 2023 with a presentation (178).
- OSSIGENO SINGOLETTO, ACIDO IPOCLOROSO E IPOCLORITO DI SODIO NEL TRATTAMENTO NELLE FERITE NON HEALING CON OSTEOMIELITE NON OPTION (ACTIMARIS)
